Removing Incentives To Lower Drug Prices Isn’t Pharma ‘Reform’

Tuesday, January 14th 2025, 12:37:28 pm
article
Delinking legislation is a giveaway to the pharmaceutical industry that will prove costly to taxpayers and Part D enrollees.
Breaking
https://spectator.org/the-lemon-test-2-0/?utm_source=rss&utm_medium=rss&utm_campaign=the-lemon-test-2-0...
With the recent news of massive layoffs at the venerable Washington Post, we are hearing from many corners that democracy itself is under siege, the earthquake being the Donald Trump presidency....
loading...